A Detroit music festival has dropped its controversial plan to charge white concertgoers twice as much as people of color — saying it was for the “safety of the community” following a furious backlash. The AfroFuture Fest sparked outrage with its ticketing model for the August 3 event that saw people of color paying a… Read More: Music festival will no longer charge white people more for… »
Medical data is only as valuable as the uses it’s put toward. When shared between patients, providers, and payers, data becomes a tool for improving health outcomes and the healthcare experience. But as we gather and use more data, we also create more risk. Whenever data is transmitted between systems, there’s a chance it could… Read More: 3 key steps to liberate data without raising liability »
While most rheumatoid arthritis cases generally affect adults, it doesn’t mean young children and adolescents are immune from this disease. Juvenile idiopathic arthritis (JIA), more known as juvenile rheumatoid arthritis, is a category that focuses on other several forms of chronic arthritis in children. JIA was first known as juvenile rheumatoid arthritis in the U.S.… Read More: This rheumatologic disease targets children »
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Print this page NEWTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved oral Xpovio (selinexor), a nuclear export inhibitor, in combination… Read More: FDA Approves Xpovio (selinexor) for the Treatment of Patients with… »